Back to search

Belgium· BE-AMP-SAM538933-00

Luxturna 5 10*12 vg/ml

A voretigene neparvovec product containing voretigene neparvovec, registered in Belgium by Novartis Europharm. The same ATC class is registered in 13 of our 19 countries.

ATC S01XA27

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedLuxturna 5 10*12 vg/mlATCS01XA27REGISTER NO.BE-AMP-SAM538933-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Voretigene neparvovec is registered in 13 of 19 countries.

Countries holding a registration under ATC S01XA27 (voretigene neparvovec), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose

Voretigene neparvovec · ATC S01XA27

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Voretigene Neparvovec
Manufacturer
Novartis Europharm
Country
Belgium (BE)
ATC code
S01XA27
ATC class
Voretigene neparvovec
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    7729668
  • be_apb
    3916798

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ec5b4e75-c409-4d4c-9575-8b4eb6d2443e
GET /v1/drugs/ec5b4e75-c409-4d4c-9575-8b4eb6d2443e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentrate and solvent for solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Luxturna 5 10*12 vg/ml",
  "name_fr": "Luxturna 5 10*12 vg/ml",
  "name_nl": "Luxturna 5 10*12 vg/ml",
  "amp_code": "SAM538933-00",
  "strengths": null,
  "pack_count": 1,
  "substances": [
    "Voretigene Neparvovec",
    "Disodium Hydrogen Phosphate Dihydrate",
    "Sodium Chloride",
    "Sodium Dihydrogen Phosphate Monohydrate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Voretigene Neparvovec",
  "authorisation_numbers": [
    "EU/1/18/1331/001"
  ]
}

See everything about voretigene neparvovec.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.